In late 2013, Allergan received FDA approval for the newest hyaluronic acid filler on the market – JUVÉDERM VOLUMATM XC (VOLUMA). This is a mid-face hyaluronic filler that’s expected to last two years. Voluma XC is the latest of the JUVÉDERM® range of hyaluronic acid fillers and is the ONLY FDA-approved filler to restore mid-face volume loss. It is approved for use in the central cheeks and cheekbone. This is the one and only filler that can be used to create higher cheekbones!
According to a leading anti-aging experts, an attractive face is characterized by smooth, round contours, high cheekbones, and a thin, well-defined jaw line. These features together comprise the ‘triangle of beauty’ or ‘heart of face’, with its base at the forehead and the peak below at the chin. This is what VOLUMA helps achieve.
Created by Allergan, the makers of BOTOX and JUVÉDERM, VOLUMA is the first and only FDA-approved filler to instantly add volume to the cheek area. VOLUMA is an injectable hyaluronic acid gel for deep injection in the cheek area to correct age-related volume loss. Hyaluronic acid is a naturally occurring substance in your body that helps to add volume and hydration, and the unique cross-linking of VOLUMA allows it to be a thicker, plumper gel than other hyaluronic acid fillers. Additionally, VOLUMA is unique because it is less hydrophilic than other JUVÉDERM products, meaning it pulls less water to itself after injection. What does this mean for you? Less swelling! VOLUMA has been shown to last up to two years when injecting amounts for full correction.
Several years ago, Allergan introduced XC products to their JUVÉDERM line—now including VOLUMA. These products are the same formulations but with lidocaine already in them.
For more information about VOLUMA, including all FDA information and a photo gallery of before and after, please visit the Allergan VOLUMA website at www.juvederm.com.
VOLUMA is injected under the skin into three main areas of the cheek. The exact placement and amount will depend upon each patient’s volume loss in these areas.